Target intelligence / Profile preview

Barttin CLCNK-type accessory beta subunit pseudogene 3 (BSNDP3)

Target
BSNDP3
Molecular classification
Other (pseudogene)
01

Overview

BSNDP3 is a pseudogene derived from the BSND (barttin) gene, which encodes an accessory beta subunit for chloride channels. The functional BSND protein is essential for kidney salt reabsorption and hearing, operating as a chaperone and regulatory subunit for CLCNKA and CLCNKB channels. BSNDP3, however, does not encode a functional protein, nor does it participate in chloride transport or serve as a molecular drug target. Its primary significance is in genomic context; it may be referenced in gene mapping or transcriptome analysis but does not have direct biological function, clinical implications, or relevance to drug discovery. If your interest is in therapeutic targets related to barttin or chloride channels, focus on the functional BSND gene and protein, not the BSNDP3 pseudogene.

Other names
barttin CLCNK-type chloride channel accessory beta subunit pseudogene 3barttin CLCNK-type accessory beta subunit pseudogene 3BSNDP3
02

Mechanism of action

None applicable to this pseudogene; mechanisms of action are relevant to the functional BSND protein and associated chloride channels

03

Biological functions

None established; pseudogenes are generally non-functional genomic elements derived from other genes
04

Disease associations

None directly associated; disease roles pertain to the functional BSND gene, not its pseudogenes
05

Safety considerations

None specific; as a pseudogene, there are no direct therapeutic challenges or safety concerns reported

Beyond the preview

Go deeper on Barttin CLCNK-type accessory beta subunit pseudogene 3 (BSNDP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Barttin CLCNK-type accessory beta subunit pseudogene 3 (BSNDP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call